These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26410418)

  • 21. Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence.
    Medina G; Briones-García E; Cruz-Domínguez MP; Flórez-Durante OI; Jara LJ
    Autoimmun Rev; 2017 Apr; 16(4):352-354. PubMed ID: 28216071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
    Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D
    J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped).
    Serrano M; Martinez-Flores JA; Norman GL; Naranjo L; Morales JM; Serrano A
    Front Immunol; 2019; 10():1031. PubMed ID: 31134087
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
    Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J; Sun S; Yan Q; Bao C; Fu Q
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.
    Chayoua W; Kelchtermans H; Gris JC; Moore GW; Musiał J; Wahl D; de Groot PG; de Laat B; Devreese KMJ
    J Thromb Haemost; 2020 Jan; 18(1):169-179. PubMed ID: 31519058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome: aPS/PT antibodies in primary antiphospholipid syndrome.
    Núñez-Álvarez CA; Hernández-Molina G; Bermúdez-Bermejo P; Zamora-Legoff V; Hernández-Ramírez DF; Olivares-Martínez E; Cabral AR
    Thromb Res; 2019 Feb; 174():141-147. PubMed ID: 30612005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
    de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
    Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome.
    Bećarević M
    J Thromb Thrombolysis; 2016 Nov; 42(4):552-7. PubMed ID: 27307251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.